ADE LLC’s Boston Scientific BSX Stock Holding History

ADE LLC’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-221	Closed	-$10K	–	102
2021 Q3	$10K	Hold	221	–	–	0.01%	197
2021 Q2	$9K	Sell	221 -37	-14%	-$1.56K	0.01%	212
2021 Q1	$10K	Hold	258	–	–	0.01%	192
2020 Q4	$9K	Buy	+258	New	+$9.3K	0.01%	266

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

ADE LLC's BSX Position: Q4 2021 in Review

ADE LLC sold out of Boston Scientific (BSX) in Q4 2021, closing a stake of 221 shares — an estimated $10K sold.

ADE LLC first reported a position in BSX in Q4 2020 and held it in 4 quarters. The position peaked at $10K in Q3 2021. 888 funds tracked by Wall St. Rank hold BSX as of Q4 2021.

ADE LLC reported no remaining Boston Scientific position as of Q4 2021 after selling out during the quarter.
ADE LLC sold 221 Boston Scientific shares in Q4 2021, an estimated $10K.
ADE LLC first reported a position in Boston Scientific in Q4 2020 and held it in 4 quarters.
ADE LLC's Boston Scientific position peaked at $10K in Q3 2021.
888 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2021.

Based on ADE LLC's 13F filing for Q4 2021, filed 14 Feb 2022.